Dejerine-Sottas disease is a dubious disease in the field of the nervous system, with complex clinical outcomes that often involve multi-system burdens. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory tests and pathological activation.
The platform can help align national and international authorities with teams of experts to provide accurate diagnosis and treatment plans. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the neural system diseases that have previously been difficult to treat have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment according to changes in disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Dejerine-Sottas disease. The platform serves a team of nationally and internationally authoritative experts in the field of neural system matching in China. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.